Ledger.Open graph →
SEC Form D · filed October 23, 2013

Revance Therapeutics, Inc

Offering
$30.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Vicente Trelles · Newark, CADirectorRonald Eastman · Newark, CADirectorFrank Kung · Newark, CADirectorRobert Byrnes · Newark, CADirectorJonathan Tunnicliffe · Newark, CADirectorPhyllis Gardner · Newark, CADirectorJim Glasheen · Newark, CADirectorDan Beecroft · Boca Raton, FLDirectorBlake Beecroft · Boca Raton, FLDirectorToney Jennings · Austin, TXDirectorDaniel M. Teal · Austin, TXDirectorRichard Teal · Austin, TXDirectorJan Steenbrugge · Boston, MADirectorGeorge Bashforth · GRAND CAYMAN, Cayman IslandsDirectorDaniel L. Browne · Newark, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗